Corbion
2.10.2026 07:00:00 CEST | Globenewswire | Press release
Corbion announces CEO Olivier Rigaud to step down at the end of current term and proposed appointment of Alexander Wessels to the Supervisory Board
Corbion announces CEO Olivier Rigaud to step down at the end of current term and proposed appointment of Alexander Wessels to the Supervisory Board
Corbion today announces that CEO Olivier Rigaud has informed the Supervisory Board that he will not seek a third term as CEO when his current appointment expires at the Annual General Meeting of Shareholders (AGM) on 12 May 2027.
After eight years as CEO, Olivier believes the end of his current term will be the right moment to hand over leadership of the company. During his tenure, he has guided Corbion through a period of significant transformation and strengthened the company's position for future growth and value creation. Olivier will remain fully committed to Corbion and continue to lead the company until the AGM on 12 May 2027, with a continued focus on improving performance, strengthening execution and advancing the company's strategic priorities.
The Supervisory Board has initiated a succession process to identify Corbion's next CEO. The Supervisory Board is confident that the planned transition timeline provides ample opportunity to ensure continuity of leadership, a smooth handover, and continued focus on delivering long term value for customers, employees, shareholders and other stakeholders.
In addition, the Supervisory Board intends to nominate Alexander (Xander) Wessels for appointment as a member of the Supervisory Board at an Extraordinary General Meeting.
Xander Wessels, a Dutch national, brings extensive experience in the life sciences, specialty chemicals and food ingredients industries, with deep expertise in strategy, operational excellence, international business leadership and value creation. Throughout his career, he has held a number of senior leadership positions, including Chief Executive Officer of Caldic, Chief Executive Officer of Archroma, and President and Chief Executive Officer of DSM Pharmaceutical Products. Earlier in his career, he also held senior leadership roles within DSM and Campina. Currently, he serves as Chair of the Supervisory Board of NRG PALLAS and Chair of Enza Zaden, and is a member of the Board of Directors of Archroma.
The Supervisory Board believes that Mr. Wessels' experience in leading international B2B companies, driving transformation and operational performance, and serving on supervisory boards will be highly valuable as Corbion continues to execute BRIGHT 2030, strengthen performance and create long-term value for stakeholders.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Chongqing Changan Automobile Co., Ltd.14.10.2026 00:58:26 CEST | Press release
CHANGAN Showcases Efficient Powertrains and Intelligent Safety at Mondial de l'Auto 2026
YYForce Inc.13.10.2026 22:05:00 CEST | Press release
YYForce Brings Humanoid Robots to Hospitality in Landmark Partnership with Novotel & Mercure Singapore on Stevens
Hebrew University of Jerusalem13.10.2026 19:14:30 CEST | Press release
Robotic Surgery Enables Effective and Safe Repair of Hard-to-Reach Abdominal Hernias
TekniPlex13.10.2026 18:57:56 CEST | Press release
TekniPlex Healthcare to Showcase Capabilities Enabling the Next Generation of Medical Device Solutions at MD&M Midwest 2026
Chongqing Changan Automobile Co., Ltd.13.10.2026 18:22:40 CEST | Press release
Changan Automobile Unveils Multiple New Models at Mondial de l'Auto 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom